Deka Bank Deutsche Girozentrale Deciphera Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$10.11 - $16.54 $505,500 - $827,000	50,000 New	50,000 $818,000
Q3 2021 Oct 22, 2021	SELL	$26.46 - $37.15 $433,944 - $609,260	-16,400 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$32.73 - $47.95 $654,599 - $959,000	-20,000 Reduced 54.95%	16,400 $591,000
Q4 2020 Mar 12, 2021	SELL	$51.77 - $66.18 $93,186 - $119,124	-1,800 Reduced 4.71%	36,400 $1.99 Million
Q3 2020 Oct 29, 2020	BUY	$43.8 - $58.16 $1.67 Million - $2.22 Million	38,200 New	38,200 $1.86 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.